Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events european academy allergy clinical immunology eaaci 2016 annual congress
… Draft Guidance: Crucial Advancement Toward More Inclusive Clinical Trials Share on: July 15, 2024 Contributed by: Ari … belongs to a racial or ethnic minority. However, clinical trials for new drugs predominantly involve White … updates on their progress toward enrollment goals in annual reports to the FDA. Importantly, the guidance allows …
… time. RTI was 393 out of 500 companies on the seventh annual ranking. “It’s a tremendous honor to be included on … for Women in 2018 and 2022 Best Midsize Employers in 2016, 2017, 2018, 2019, 2021 and 2022 Learn more about …
… our Barcelona based team, we are a partner center of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) which is led by the European Medicines Agency. We are dedicated to excellence in … a charter member of the newly-formed SIGMA Consortium , a European federated professional network of excellence created …
… 15th Clinical Trials on Alzheimer's Disease (CTAD) Share on: … at RTI Health Solutions, will be presented at the 15th Clinical Trials on Alzheimer's Disease. Economic burden of …
… Mond T, Marshall G, Sweeney C, Davenport E, Wang J. @AANP_NEWS #AANP23 …
… Challenges & Solutions in Analysis of PROs in Oncology Clinical Trials Share on: Wednesday, March 21, 2018, 10 - … Unique Challenges with Patient-Reported Outcomes in Clinical Trials Collecting, analyzing, and interpreting … in cancer trials. Why traditional statistical methods for clinical trials can lead to biased results when applied to …
… receiving their first treatment during July 2012 to June 2016. The combination of targeted agents bendamustine and … of 31% in 2015, but its use had declined sharply by early 2016. Similarly, other rituximab-based combination … inhibitor, ibrutinib, increased sharply to 25.8% by early 2016. Its use increased among both younger patients and those …
… 12, 2022 Most of what we know about treatments, adverse events, and the overall survival of patients with chronic … leukemia (CLL) and mantle cell lymphoma (MCL) comes from clinical trials. However, confirmatory real-world evidence, … suboptimal health results and economic consequences. The annual economic burden of adverse events and other …
… Factual presentations of results from studies, including clinical studies (i.e., no characterizations or conclusions … for Formulary Submissions Guidance Version 4.0 (April 2016) The AMCP Format v4.0 states that manufacturers may use … Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; the company’s …
… heart attacks, anginas, and arrhythmias. In 2013, the European Medicines Agency evaluated the benefits and risks of … of cilostazol in Europe. The study was conducted in 5 European populations - Aragon and Catalonia in Spain, Sweden, … measures in 2013. After labeling changes, the annual prevalence of cilostazol decreased in all the study …